Notice: Multiple additions to the Prescription Drug List (PDL) [2026-08-27]
Document to announce multiple updates to the Prescription Drug List.
View ArticleInformation about the Prescription Drug List: Notice
Health Canada is pleased to announce the publication of new web pages: Overview of the Prescription Drug List and Processes to Amend the Prescription Drug List. Together these pages are replacing the...
View ArticleNotice: Multiple additions to the Prescription Drug List (PDL) [2026-06-25]
Document to announce multiple updates to the Prescription Drug List.
View ArticleHealth Canada has changed the Prescription Drug List qualifier related to...
Document to announce an amendment to the qualifier for melatonin on the Prescription Drug List.
View ArticleGlucagon for injection supply in Canada: Notice [2026-05-29]
Glucagon for injection is used for the emergency treatment of severe hypoglycemia (low blood sugar). Beginning in May 2023, we allowed Amphastar Pharmaceuticals Inc. to import US-authorized Glucagon...
View ArticleHealth Canada is changing the Prescription Drug List qualifier related to...
Document to announce Health Canada’s intent to revise the qualifier for melatonin on the Prescription Drug List.
View ArticleNotice of consultation: Proposed change to the veterinary omeprazole listing...
Document to announce a consultation on the proposal to change the veterinary omeprazole listing on the Prescription Drug List (PDL).
View ArticleNotice: Multiple additions to the Prescription Drug List (PDL) [2026-04-30]
Document to announce multiple updates to the Prescription Drug List.
View ArticlePhenytoin sodium capsules and phenytoin chewable tablets in short supply: Notice
Phenytoin sodium capsules and phenytoin chewable tablets are used to control seizures. Supply constraints could impact the availability of these drugs in Canada until early May 2026.
View ArticlePharmaceutical and Life Sciences Sector Task Force
The Pharmaceutical and Life Sciences Sector Task Force is a joint federal initiative led by Health Canada and Innovation, Science and Economic Development Canada. The task force will support reliable...
View ArticleNotice: Multiple additions to the Prescription Drug List (PDL) [2026-02-26]
Documents to announce multiple updates to the Prescription Drug List.
View ArticleNotice of consultation: Removing zuranolone from the Prescription Drug List...
Document to announce a consultation on the proposal to remove zuranolone from the Prescription Drug List (PDL).
View ArticleHealth product shortages in Canada: Fiscal year 2024 to 2025 in review
An overview of drug and medical device shortages in Canada for the 2024 to 2025 fiscal year.
View ArticleNotice of amendment: Revisions to the Prescription Drug List for nicotine...
Documents to announce that Health Canada has revised the qualifier of the “Nicotine or its salts” listing on the human use part of the Prescription Drug List (PDL).
View ArticleConsultation: Draft guidance on decentralized clinical trials
Health Canada has drafted a guidance document on decentralized clinical trials. The draft guidance outlines regulatory considerations and practical strategies for conducting clinical trials with...
View ArticleConsultation: Modernizing the framework for clinical trials
Health Canada is seeking feedback on the proposed Clinical Trials Regulations for drugs (pharmaceuticals, biologics and radiopharmaceuticals) and on multiple guidance documents related to the proposal.
View ArticleNotice: Multiple Additions to the Prescription Drug List (PDL)
Documents to announce multiple updates to the Prescription Drug List.
View ArticleConsultation: Adding melatonin for sleep-related use in the pediatric...
Document to announce the proposal to revise the qualifier for melatonin on the Prescription Drug List.
View ArticleNotice of amendment: Addition of melatonin to the Prescription Drug List
The purpose of this Notice of Amendment is to announce the addition of "melatonin or its salts” to the human use part of the Prescription Drug List (PDL). This addition will not be made to the...
View ArticleHealth Canada and the Public Health Agency of Canada’s report on red tape...
Health Canada and the Public Health Agency of Canada have conducted a broad review of regulations and program administration to identify outdated, inefficient or duplicate regulations that hinder...
View Article